Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$518,230,610
-$121,557,601 QoQ
Shares Held
2,040,519
-22.0% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#98
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital International Investors holds $21,276,574,646 across 8 Drug Manufacturers - General names. JNJ ranks #6 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,734,768 | $6,878,453,355 | |
| 2 | AZN |
Astrazeneca PLC
|
34,576,070 | $6,556,314,393 | |
| 3 | ABBV |
AbbVie Inc.
|
15,638,631 | $3,935,305,104 | |
| 4 | MRK |
Merck & Co., Inc.
|
15,386,689 | $1,977,189,536 | |
| 5 | AMGN |
Amgen Inc
|
1,668,778 | $604,297,889 | |
| 6 | JNJ |
Johnson & Johnson
This page
|
2,040,519 | $518,230,610 | |
| 7 | NVO |
Novo Nordisk A S
|
9,721,180 | $466,033,369 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,913,752 | $340,750,390 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $518,230,610 | 2,040,519 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $639,788,211 | 2,617,363 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,546,129,865 | 7,471,031 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $716,657,571 | 3,865,050 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $91,450,814 | 598,696 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $613,633,539 | 3,700,154 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $734,047,444 | 5,075,698 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $821,733,333 | 5,070,550 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $740,974,636 | 5,069,613 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,713,888,815 | 17,155,881 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,543,214,856 | 28,985,676 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,514,603,609 | 28,986,219 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,605,725,588 | 27,825,795 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,650,761,175 | 17,101,685 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,103,679,379 | 17,569,654 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,068,293,680 | 18,782,405 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,463,441,099 | 19,511,245 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,550,439,728 | 20,032,950 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $3,456,677,884 | 20,206,219 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,322,318,245 | 20,571,630 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,155,532,428 | 19,154,622 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,005,298,019 | 18,285,963 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,875,688,278 | 18,272,260 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $2,718,601,801 | 18,260,356 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,565,526,309 | 18,243,094 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,193,406,920 | 16,726,965 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||